Research Articles
TimiGP: A Novel Computational Method for Inferring Prognostic Cell-Cell Interactions from Bulk Transcriptomic Data
This article provides a comprehensive guide to TimiGP (Time Machine for Gene Pairs), a computational framework designed to infer cell-cell interactions (CCIs) that influence patient prognosis from bulk RNA-sequencing data.
Decoding Immune Checkpoint Resistance: Comparing Anti-CTLA-4 vs. Anti-PD-1/PD-L1 Mechanisms in Cancer Therapy
This article provides a comprehensive analysis of the distinct and overlapping resistance mechanisms to anti-CTLA-4 and anti-PD-1/PD-L1 immune checkpoint inhibitors (ICIs).
Adenosine Pathway Inhibitors and Immunotherapy: A Comparative Guide for Cancer Research and Drug Development
This article provides a comprehensive analysis of adenosine pathway inhibitors (e.g., targeting CD73, CD39, A2AR) in combination with immune checkpoint blockade.
Comparative Sensitivity of CSC Detection Methods: A 2024 Guide for Cancer Researchers & Drug Developers
This article provides a comprehensive, evidence-based analysis for researchers and drug development professionals on the sensitivity, advantages, and limitations of current Cancer Stem Cell (CSC) detection methodologies.
CAR-T vs CAR-NK Cell Therapy: A Comprehensive 2024 Comparison of Efficacy, Safety, and Clinical Applications
This article provides a detailed comparative analysis of Chimeric Antigen Receptor (CAR) T-cell and Natural Killer (NK) cell therapies, tailored for researchers and drug development professionals.
VEGF Blockade vs. Immune Checkpoint Inhibition: A Comparative Analysis of Efficacy, Mechanisms, and Clinical Applications in Oncology
This article provides a comprehensive comparative analysis of anti-VEGF agents and immune checkpoint inhibitors (ICIs), two cornerstone classes of cancer therapeutics.
ICI Combinations: A Comparative Analysis of Efficacy, Mechanisms, and Clinical Applications in Cancer Therapy
This review provides a comprehensive, evidence-based analysis of the comparative effectiveness of different immune checkpoint inhibitor (ICI) combinations for researchers, scientists, and drug development professionals.
Neoantigen Load as a Predictive Biomarker: A Cross-Cancer Analysis of Immunotherapy Efficacy and Resistance Mechanisms
This article provides a comprehensive, up-to-date comparative analysis of tumor neoantigen burden as a determinant of immune checkpoint inhibitor (ICI) response across major cancer types.
CD44 vs CD133 in Cancer Prognosis: A Comparative Analysis of Biomarker Utility, Detection Methods, and Clinical Relevance
This article provides a comprehensive comparative analysis of CD44 and CD133 as prognostic markers in cancer.
Decoding the Tumor Immune Microenvironment: A Comparative Analysis of GCB vs ABC Subtypes in DLBCL
This article provides a comprehensive comparative analysis of the immune microenvironment in Germinal Center B-cell (GCB) and Activated B-cell (ABC) subtypes of Diffuse Large B-cell Lymphoma (DLBCL).